|Trial status||Trial closed|
Interventional with experimental drug
|Phase||Trial phase 1|
|Inclusion criteria||RECIST 1.1 after standard trerapy|
The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.